EPFL7 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of EPFL7 Antibody

The term "EPFL7 Antibody" can refer to different molecules depending on the context. Recent research highlights an antibody called P2G3, discovered by scientists at Lausanne University Hospital (CHUV) and EPFL, that effectively neutralizes SARS-CoV-2 variants, including Omicron sub-variants . Additionally, "EGFL7 antibody" (Epidermal Growth Factor-Like protein 7 antibody) is a commercially available antibody targeting the EGFL7 protein, which is involved in vascular tubulogenesis . Another research direction involves Epidermal Growth Factor Receptor (EGFR) inhibitors, with studies focusing on identifying and developing molecules that can overcome drug resistance in cancer treatments .

Discovery and Function

P2G3 is a monoclonal antibody that exhibits potent neutralizing activity against all SARS-CoV-2 variants of concern, including Omicron sub-variants . It was isolated from a donor previously infected and vaccinated twice . The antibody functions by binding to a specific region of the Spike protein, preventing the virus from binding to the ACE2 receptor on cells targeted by the infection .

Mechanism of Action

P2G3's mechanism of action involves binding to a conserved region of the Spike protein, which inhibits the virus's ability to attach to the ACE2 receptor on host cells . This interaction halts the viral replication process, allowing the patient’s immune system to clear SARS-CoV-2 from the body .

Complementarity with P5C3

Structural studies indicate that P2G3 and P5C3, another broad-spectrum antibody, bind to distinct sites on the Spike protein, demonstrating their complementarity . This complementarity means that P2G3 neutralizes mutants that escape P5C3, and vice versa .

Prophylactic and Therapeutic Efficacy

  • Prophylactic Use When used prophylactically, P2G3 provides complete protection against Omicron BA.1 variant infection in primates .

  • Therapeutic Use In combination with P5C3, P2G3 is highly effective in blocking virus multiplication in already infected animals .

Clinical Trials

Clinical trials to confirm the neutralizing activity of P2G3 against Omicron BA.4 and BA.5 variants began in August 2022 .

General Information

The Anti-EGFL7 antibody [EPR22603-113] (ab256451) is a Rabbit Recombinant Monoclonal Antibody that targets human Epidermal Growth Factor-Like protein 7 (EGFL7) . It is suitable for various applications, including WB (Western Blot), ICC/IF (Immunocytochemistry/Immunofluorescence), and IHC-P (Immunohistochemistry – Paraffin-embedded sections) .

Functions of EGFL7

EGFL7 regulates vascular tubulogenesis in vivo, inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration, and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis .

Properties

PropertyDescription
ClonalityMonoclonal
Host SpeciesRabbit
IsotypeIgG
ApplicationsWB, ICC/IF, IHC-P
ReactivityHuman
BufferPBS, 40% Glycerol, 0.05% BSA
Storage+4°C for short term, -20°C for long term (aliquot)

Development of Novel Inhibitors

Research has focused on developing third-generation EGFR inhibitors to overcome resistance issues . One approach involves analyzing EGFR protein crystal complexes to identify potent inhibitors .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M Phosphate-Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
EPFL7 antibody; At1g71866 antibody; F14O23 antibody; F17M19EPIDERMAL PATTERNING FACTOR-like protein 7 antibody; EPF-like protein 7) [Cleaved into: MEPFL7] antibody
Target Names
EPFL7
Uniprot No.

Target Background

Function
This antibody targets a protein involved in the control of stomatal patterning.
Database Links

KEGG: ath:AT1G71866

STRING: 3702.AT1G71866.1

UniGene: At.75531

Protein Families
Plant cysteine rich small secretory peptide family, Epidermal patterning factor subfamily
Subcellular Location
Secreted.

Q&A

What is the EPFL7 protein and what biological systems express it?

EPFL7 is a member of the epidermal patterning factor-like family in Arabidopsis thaliana (Mouse-ear cress). This protein is part of the signaling peptide family involved in developmental regulation pathways. As a research target, EPFL7 requires specific antibody-based detection methods due to its relatively low expression levels in plant tissues. When designing experiments to study EPFL7, researchers should consider using samples from various developmental stages, as expression patterns may vary throughout the plant life cycle. The commercially available antibody against EPFL7 (such as the polyclonal antibody CSB-PA503985XA01DOA) is raised against recombinant Arabidopsis thaliana EPFL7 protein .

What applications are most effective for EPFL7 antibody use?

The EPFL7 antibody has been validated for several key applications:

  • ELISA (Enzyme-Linked Immunosorbent Assay): Effective for quantitative measurement of EPFL7 protein levels

  • Western Blot (WB): Useful for detecting the presence and relative abundance of EPFL7 in tissue samples

When planning experimental approaches, researchers should note that antibody performance may vary depending on sample preparation methods. For optimal results, follow manufacturer-recommended dilutions while also performing validation tests in your specific experimental system .

What are recommended storage conditions for maintaining EPFL7 antibody activity?

For maximum stability and longevity of your EPFL7 antibody:

  • Store at -20°C or -80°C upon receipt

  • Avoid repeated freeze-thaw cycles, which can significantly reduce antibody activity

  • For antibodies in liquid form, store in the recommended buffer (typically with preservatives like 0.03% Proclin 300)

  • Storage in 50% glycerol helps maintain antibody stability during freeze-thaw cycles when necessary

How should researchers design proper controls when using EPFL7 antibodies?

Proper experimental design requires rigorous controls:

Control TypePurposeImplementation
Negative controlAssess non-specific bindingSample lacking EPFL7 expression (knockout/knockdown)
Positive controlConfirm antibody functionalityRecombinant EPFL7 protein or known EPFL7-expressing tissue
Secondary antibody controlDetermine background signalPrimary antibody omitted, secondary antibody only
Blocking peptide controlVerify specificityPre-incubate antibody with blocking peptide prior to use

Implementing these controls is especially important when working with polyclonal antibodies like the EPFL7 antibody (CSB-PA503985XA01DOA), as they may show cross-reactivity with structurally similar proteins in the EPF family .

What sample preparation methods optimize EPFL7 detection in plant tissues?

Effective sample preparation is critical for successful EPFL7 detection:

  • Tissue homogenization: Use liquid nitrogen grinding followed by buffer extraction

  • Buffer selection: For plant tissues, phosphate-buffered saline (PBS, pH 7.4) with protease inhibitors is recommended

  • Protein extraction: Include 0.1-1% detergent (Triton X-100 or NP-40) to solubilize membrane-associated proteins

  • Centrifugation: Clear lysates at 12,000-15,000 g for 10-15 minutes at 4°C

  • Protein quantification: Use Bradford or BCA assay to normalize protein loading

These methods help ensure consistent and reproducible results when working with EPFL7 antibodies across different experimental systems.

How can researchers troubleshoot non-specific binding when using EPFL7 antibody?

Non-specific binding is a common challenge when working with polyclonal antibodies. To address this issue:

  • Optimize blocking conditions: Test different blocking agents (5% non-fat milk, 3-5% BSA, or commercial blocking buffers)

  • Adjust antibody dilution: Test serial dilutions to find optimal concentration (typically 1:1000-1:4000 for Western blots)

  • Increase washing stringency: Use PBS-T (PBS with 0.05-0.1% Tween-20) and increase washing duration

  • Pre-absorb antibody: Incubate with tissues lacking EPFL7 to remove cross-reactive antibodies

  • Optimize incubation conditions: Test various temperatures (4°C, room temperature) and durations

For particularly challenging samples, consider using antigen retrieval methods commonly employed in immunohistochemistry to improve epitope accessibility while maintaining tissue morphology.

What approaches can enhance immunolocalization of EPFL7 in plant tissues?

Successful immunolocalization of EPFL7 requires specialized techniques:

  • Fixation optimization: Test both aldehyde-based (4% paraformaldehyde) and alcohol-based fixatives

  • Embedding method selection: Paraffin embedding works well for general morphology, while cryosectioning better preserves antigenicity

  • Antigen retrieval: Heat-induced epitope retrieval (HIER) using citrate buffer (pH 6.0) often improves antibody binding

  • Signal amplification: Consider tyramide signal amplification (TSA) to detect low-abundance EPFL7

  • Counterstaining: Use differential interference contrast (DIC) or fluorescent markers for cellular structures

These advanced approaches can significantly improve the sensitivity and specificity of EPFL7 detection in complex plant tissues.

How can researchers quantitatively assess EPFL7 protein levels using antibody-based methods?

For quantitative analysis of EPFL7 expression:

  • Quantitative Western Blot:

    • Use internal loading controls (actin, tubulin, or GAPDH)

    • Apply density-based quantification software

    • Generate standard curves with recombinant protein

  • ELISA-based quantification:

    • Develop sandwich ELISA with capture and detection antibodies

    • Use purified recombinant EPFL7 for standard curve generation

    • Validate with spike-in recovery experiments

  • Immunoprecipitation followed by mass spectrometry:

    • Provides absolute quantification capabilities

    • Allows detection of post-translational modifications

    • Enables identification of interaction partners

When reporting quantitative results, always include statistical analysis methods and clearly state biological versus technical replication numbers.

How do different fixation protocols affect EPFL7 epitope preservation?

Fixation method selection significantly impacts antibody binding:

Fixation MethodAdvantagesDisadvantagesBest For
4% ParaformaldehydeGood morphology preservationMay mask some epitopesImmunofluorescence
100% MethanolBetter antigen preservationPoorer morphologyWestern blotting
AcetoneMinimal epitope maskingPoor structural preservationQuick immunostaining
GlutaraldehydeExcellent ultrastructureSignificant autofluorescenceElectron microscopy

For EPFL7 detection, a combination approach using 4% paraformaldehyde followed by partial permeabilization with a low concentration of detergent often yields optimal results for balancing epitope preservation and structural integrity.

What advantages does EPFL7 antibody offer over transcript-level analysis?

Protein-level detection using EPFL7 antibody provides several advantages over transcript analysis:

  • Post-transcriptional regulation: Detects actual protein levels which may not correlate with mRNA abundance

  • Protein localization: Enables subcellular localization studies not possible with transcript analysis

  • Post-translational modifications: Can detect modified forms of EPFL7 depending on antibody specificity

  • Protein stability assessment: Allows studies of protein turnover rates and stability

  • Protein-protein interactions: Facilitates co-immunoprecipitation studies to identify interaction partners

When designing comprehensive studies, combining antibody-based protein detection with transcript analysis provides the most complete picture of EPFL7 regulation and function.

How can researchers validate EPFL7 antibody specificity in transgenic or mutant plant lines?

Rigorous validation of antibody specificity is essential, particularly in genetically modified systems:

  • Genetic knockout/knockdown validation:

    • Test antibody in EPFL7 knockout/knockdown lines

    • Signal should be absent or significantly reduced

  • Overexpression validation:

    • Test in EPFL7 overexpression lines

    • Signal should be proportionally increased

  • Epitope tagging approach:

    • Create epitope-tagged EPFL7 constructs

    • Compare detection using EPFL7 antibody versus tag-specific antibody

  • Preabsorption test:

    • Preincubate antibody with purified antigen

    • Should eliminate specific signal while leaving non-specific binding

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.